BSEGAGAN GASES LTD.· Chemicals & PetrochemicalsHighNeutral
Announced Mon, 10 Aug, 2026 · 15:27 IST

Gagan Gases Q1 FY27 Results: PAT at Rs 3.93L vs Loss a Year Ago

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+2.9%Reaction day
₹18.36
prior close
₹18.90
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.1%+3.0% vs market
Industrial Gases peers, median of 5sector+1.2%+1.7% vs sector

On the reaction day the stock moved 3.0 pts more than Nifty Microcap 250 and 1.7 pts more than its Industrial Gases peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+2.9-0.1+3.0+1.2+1.7
Next day
+5.1-0.2+5.3-0.3+5.4
2d
+8.7+0.1+8.5+0.0+8.7
3d
+6.2+0.3+5.9-2.6+8.8
4d
+8.9+0.4+8.5+1.1+7.8
5d
+10.6+0.5+10.1-1.2+11.8
1w
+8.9+0.3+8.6-0.3+9.3
15d
+11.7+1.9+9.8-2.4+14.1
1m
+4.9+2.2+2.7-7.7+12.6
2m
+1.9-1.2+3.0-14.9+16.7
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Industrial Gases peers, median of 5Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Gagan Gases posted Q1 FY27 revenue of Rs 53.08L, down about 38% from Rs 85.89L a year ago. PAT swung to a profit of Rs 3.93L (EPS Rs 0.09) versus a loss of Rs 6.85L in Q1 FY26. Full year FY26 revenue was Rs 602.62L with PAT of Rs 13.97L. Other equity remains negative at minus Rs 106.72L. Auditors issued a clean limited review with no qualifications. The 40th AGM is scheduled for 26 September 2026.

Likely market impact

Revenue drop is a concern, but swing to profit from year-ago loss is positive. Negative reserves continue to be a watchpoint for long-term health.